The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of hormone receptor status and tumor subtypes on clinical behavior and outcomes of breast cancer in young BRCA carriers.
 
Luca Arecco
No Relationships to Disclose
 
Marco Bruzzone
No Relationships to Disclose
 
Anne-Sophie Hamy
No Relationships to Disclose
 
Hee Jeong Kim
Honoraria - Alvogen Korea; Takeda
 
Antonio Di Meglio
Expert Testimony - Kephren; techspert.io
 
Rinat Bernstein-Molho
Honoraria - AstraZeneca; Pfizer
Travel, Accommodations, Expenses - Pfizer
 
Florentine Hilbers
No Relationships to Disclose
 
Katarzyna Pogoda
Honoraria - AstraZeneca; Egis Pharmaceuticals; Gilead Sciences; Lilly; MSD Oncology; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; Novartis; Sandoz
Speakers' Bureau - AstraZeneca; Gilead Sciences; Lilly Poland; Novartis; Pfizer
Travel, Accommodations, Expenses - AstraZeneca; Gilead Sciences; Novartis; Roche
 
Estela Carrasco
No Relationships to Disclose
 
Kevin Punie
Honoraria - AstraZeneca; Exact Sciences; Focus Patient; Gilead Sciences; Gilead Sciences (Inst); Lilly; Lilly (Inst); Lilly (Inst); MSD; MSD (Inst); Mundipharma (Inst); Novartis; Novartis (Inst); Novartis (Inst); Pfizer; Pfizer; Pfizer (Inst); Pfizer (Inst); Roche; Roche (Inst); Seagen; Seagen (Inst)
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca (Inst); Exact Sciences; Gilead Sciences; Lilly; Lilly (Inst); Lilly (Inst); MSD (Inst); Novartis; Novartis; Novartis; Novartis; Novartis; Novartis (Inst); Novartis (Inst); Novartis (Inst); Pfizer; Pierre Fabre (Inst); Roche; Roche (Inst); Roche (Inst); Roche (Inst); Sanofi; Seagen; Teva (Inst); Vifor Pharma (Inst)
Research Funding - MSD (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Novartis; Pfizer; PharmaMar; Roche; Roche; Roche; Roche
Other Relationship - Need
 
Jyoti Bajpai
Research Funding - Lilly (Inst); Novartis (Inst); Paxman Scalp Coolers-Access device (Inst); Roche (Inst); Samsung Bioepis (Inst); Sun Pharma (Inst)
 
Elisa Agostinetto
Honoraria - AstraZeneca; Lilly; Sandoz
Research Funding - Gilead Sciences (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo Europe GmbH; Genetic Spa; Novartis
 
Nerea Lopetegui-Lia
No Relationships to Disclose
 
Ann H. Partridge
Research Funding - Novartis
Patents, Royalties, Other Intellectual Property - I receive small royalty payments for co-authoring the breast cancer survivorship section of UpToDate
 
Kelly-Anne Phillips
Research Funding - AstraZeneca (Inst)
(OPTIONAL) Uncompensated Relationships - AstraZeneca (Inst)
 
Angela Toss
Honoraria - AstraZeneca; Gilead Sciences; Lilly; MSD Oncology; Novartis; Pfizer; Seagen
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Lilly; MSD/AstraZeneca; Novartis; Pfizer; Seagen
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca; Gilead Sciences
 
Christine Rousset-Jablonski
Honoraria - Thramex (Inst)
Consulting or Advisory Role - Bristol Myers Squibb; Gédéon Richter (Inst); Roche (Inst); Theramex (Inst)
Speakers' Bureau - Bristol-Myers Squibb (Inst); Merck (Inst); Novartis (Inst)
Research Funding - Bayer (Inst); Gédéon Richter (Inst)
Travel, Accommodations, Expenses - Gédéon Richter
 
Giuseppe Curigliano
Leadership - ESMO; ESMO Open; European Society of Breast Cancer Specialists (EUSOMA=
Honoraria - Ellipses Pharma
Consulting or Advisory Role - AstraZeneca; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Celcuity; Daichi-Sankyo; Exact Sciences; Foundation Medicine; Gilead Sciences; GlaxoSmithKline; Guardant Health; Hengrui Therapeutics; Lilly; Menarini; Merck; Novartis; Pfizer; Roche/Genentech; Samsung; Seagen; Veracyte
Speakers' Bureau - AstraZeneca; Daiichi Sankyo; Exact Sciences; Foundation Medicine; Gilead Sciences; Lilly; Menarini; Novartis; Pfizer; Roche/Genentech; Samsung; Seagen
Research Funding - Merck (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daichii Sankyo; Pfizer; Roche/Genentech
 
Eva Blondeaux
Research Funding - Gilead Sciences
 
Matteo Lambertini
Consulting or Advisory Role - AstraZeneca; Exact Sciences; Gilead Sciences; Lilly; Menarini; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Seagen
Speakers' Bureau - AstraZeneca; Daiichi Sankyo; Gilead Sciences; Ipsen; Knight Therapeutics; Libbs; Lilly; Menarini; Novartis; Pfizer; Roche; Sandoz; Takeda
Research Funding - Gilead Sciences (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo Europe GmbH; Gilead Sciences; Roche